AMRN 241220 1.50C (AMRN241220C1500) Stock Options, News & Quotes

US OptionsDetailed Quotes

AMRN241220C1500

Watchlist

0.04
0.000.00%

15min DelayClose Nov 26 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Express News | Amarin Corp - Nasdaq Granted 180 Days to Regain Nasdaq Compliance
ReutersNov 22 16:52 ET
After Plunging -19.13% in 4 Weeks, Here's Why the Trend Might Reverse for Amarin (AMRN)
Zacks Nov 19 08:40 ET
Top 3 Health Care Stocks You'll Regret Missing In Q4
BenzingaNov 19 07:52 ET
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Bolt Biotherapeutics (BOLT) and Amarin (AMRN)
TipRanksNov 19 02:00 ET · Ratings
US Manufacturing Index Rises To 43, Highest Since 2020
Business TodayNov 16 02:13 ET
Amarin Corporation Announces That Investigators Will Present An Additional Subgroup Analysis From The REDUCE-IT Outcomes Trial In Patients With And Without Coronary Artery Disease History And Mechanistic Data On Eicosapentaenoic Acid At The American...
BenzingaNov 11 08:22 ET

Comments

Jaguar8

Nov 22 15:53

NEWS

$Amarin (AMRN.US)$
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On November 22, 2024, Amarin Corporation plc (the “Company”) received a notice (the “Extension Notice”) from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that Nasdaq has granted the Company an additional 180 calendar days, or until May 19, 2025, to regain compliance with the minimum bid price requi...